Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-01 Sale |
2021-02-03 4:45 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $75.31 | $753,100 | 672,548 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 6:19 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $46.4 | $464,000 | 682,548 (Direct) |
View |
| 2020-12-08 Sale |
2020-12-10 4:55 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Ultragenyx Pharmaceutical Inc. Director 10% Owner |
800,000 | $100.81 | $80,650,635 | 2,200,000 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-03 5:45 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $96.19 | $961,900 | 692,548 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-03 8:01 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $55.28 | $552,800 | 702,548 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-02 5:00 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $42.83 | $428,300 | 712,548 (Direct) |
View |
| 2020-09-03 Sale |
2020-09-04 5:05 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $45.16 | $451,600 | 722,548 (Direct) |
View |
| 2020-06-12 Purchase |
2020-06-12 6:22 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks |
450 | $33.33 | $14,999 | 950 (Direct) |
View |
| 2020-06-10 Purchase |
2020-06-10 9:59 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
1,000 | $31.69 | $31,690 | 1,475,097 (Direct) |
View |
| 2020-06-10 Purchase |
2020-06-10 9:59 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | SASSINE ANDY Chief Financial Officer |
5,000 | $29.74 | $148,700 | 273,245 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-02-10 08:31 am |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Arcturus Therapeutics Holdings Inc. 10% Owner |
0 | $0 | 843,750 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 7:41 pm |
N/A 2030-12-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks |
45,000 | $0 | 45,000 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 7:40 pm |
N/A 2030-12-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 7:40 pm |
N/A 2030-12-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO 10% Owner |
175,000 | $0 | 175,000 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 7:39 pm |
N/A 2030-12-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | SASSINE ANDY Chief Financial Officer |
100,000 | $0 | 368,235 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 7:39 pm |
N/A 2030-12-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Hughes Steven George Chief Development Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 7:37 pm |
N/A 2030-12-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Kurata Lance Chief Legal Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-08-10 Option Award |
2020-08-12 8:38 pm |
N/A 2030-08-09 |
Arcturus Therapeutics Holdings Inc. | ARCT | Kurata Lance Chief Legal Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 8:02 pm |
N/A 2030-06-21 |
Arcturus Therapeutics Holdings Inc. | ARCT | Parschauer Karah Herdman Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 8:01 pm |
N/A 2030-06-21 |
Arcturus Therapeutics Holdings Inc. | ARCT | Marquet Magda Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 8:01 pm |
N/A 2030-06-21 |
Arcturus Therapeutics Holdings Inc. | ARCT | HOLMES EDWARD W Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 8:00 pm |
N/A 2030-06-21 |
Arcturus Therapeutics Holdings Inc. | ARCT | BARLOW JAMES F Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 8:00 pm |
N/A 2030-06-21 |
Arcturus Therapeutics Holdings Inc. | ARCT | FARRELL PETER C Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-22 1:41 pm |
2019-06-19 2021-06-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Ultragenyx Pharmaceutical Inc. Director 10% Owner |
600,000 | $0 | 3,000,000 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-22 1:41 pm |
N/A N/A |
Arcturus Therapeutics Holdings Inc. | ARCT | Ultragenyx Pharmaceutical Inc. Director 10% Owner |
600,000 | $16 | 3,000,000 (Direct) |
View |